130 related articles for article (PubMed ID: 12795105)
1. [A patient with recurrent gastric cancer who developed TS-1 induced hand-foot syndrome].
Arai K; Iwasaki Y; Kimura Y; Takahashi K; Yamaguchi T; Honma S; Takahashi T
Gan To Kagaku Ryoho; 2003 May; 30(5):699-702. PubMed ID: 12795105
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy and safety of novel oral fluoropyrimidine anticancer drug, TS-1 for advanced and recurrent gastric cancer patients].
Arai K; Iwasaki Y; Kimura Y; Takahashi K; Yamaguchi T; Honma S; Takahashi T
Gan To Kagaku Ryoho; 2003 Sep; 30(9):1297-301. PubMed ID: 14518409
[TBL] [Abstract][Full Text] [Related]
3. [A clinical results of TS-1 in advanced and recurrent gastric cancer in our hospital].
Abe S; Kojima M; Tamura H; Kurihara H; Kitago M; Kobayashi T; Nakamura T; Ogihara T
Gan To Kagaku Ryoho; 2003 Jul; 30(7):963-70. PubMed ID: 12894711
[TBL] [Abstract][Full Text] [Related]
4. [A case of recurrent gastric cancer with dihydropyrimidine dehydrogenase (DPD) deficiency].
Hashimoto T; Arai K; Iwasaki Y; Saze Z; Takahashi K; Yamaguchi T; Matsumoto H; Yasutome M; Hiruma K; Yamashita Y
Gan To Kagaku Ryoho; 2006 Jul; 33(7):985-8. PubMed ID: 16835493
[TBL] [Abstract][Full Text] [Related]
5. [Clinical results of single therapy with TS-1 for advanced/recurrent gastric cancer].
Ohshima T; Yamada R; Hatori S; Kunisaki C; Makino T; Yamazaki Y; Suda T; Rino Y; Takanashi Y; Imada T
Gan To Kagaku Ryoho; 2006 Aug; 33(8):1105-10. PubMed ID: 16912529
[TBL] [Abstract][Full Text] [Related]
6. [Clinical study of TS-1 for inoperative and recurrent gastric cancer and evaluation of long survival cases].
Tanabe K; Yoshida K; Hamai Y; Ukon K; Ohta K; Hihara J; Toge T
Gan To Kagaku Ryoho; 2005 Aug; 32(8):1145-8. PubMed ID: 16121917
[TBL] [Abstract][Full Text] [Related]
7. [A trial of TS-1 administration on the basis of the pharmacokinetic study for an advanced gastric cancer patient with impaired renal function].
Yamamoto K; Imamura H; Furukawa H; Kishimoto T; Tanaka J; Oshiro R; Tatsuta M; Masutani S; Fukunaga M; Nakayama T; Takemoto H; Kondo M; Kamigaki S; Kawasaki T
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1748-51. PubMed ID: 16315929
[TBL] [Abstract][Full Text] [Related]
8. Acral lentiginosis associated with tegafur/gimeracil/oteracil (TS-1).
Park YJ; Soh BW; Lee ES
Eur J Dermatol; 2017 Apr; 27(2):209-210. PubMed ID: 28251899
[No Abstract] [Full Text] [Related]
9. [Adverse reactions to TS-1 for outpatients with recurrent head and neck cancer].
Nishino H; Shinozaki T; Ishikawa K; Tanaka H; Ichimura K
Gan To Kagaku Ryoho; 2002 Nov; 29(11):2019-23. PubMed ID: 12465408
[TBL] [Abstract][Full Text] [Related]
10. [Results of treatment of far advanced and recurrent stomach cancer with TS-1].
Johira H; Yunoki S; Kawata N; Watanabe N; Hachisuka Y; Kimura M; Uomoto M; Hatano H; Sanada E; Watanabe R; Ohmori K; Miyata N
Gan To Kagaku Ryoho; 2005 Feb; 32(2):195-9. PubMed ID: 15751632
[TBL] [Abstract][Full Text] [Related]
11. [A case of postoperative chestwall recurrence of gastric cancer responding to a combination of radiation, hyperthermia and oral administration of TS-1].
Aotake T; Yamamoto H; Tanaka F; Fujii H; Hirose Y; Matsushita T
Gan To Kagaku Ryoho; 2004 Mar; 31(3):407-9. PubMed ID: 15045950
[TBL] [Abstract][Full Text] [Related]
12. [A case of recurrent gastric cancer with peritoneal dissemination successfully treated with DJ stents against bilateral hydronephrosis and chemotherapy].
Ebisui C; Souma I; Hayashi N; Fukuchi N; Izawa H; Yoshida T; Sakita I; Hasuike Y; Fujimoto T
Gan To Kagaku Ryoho; 2004 Oct; 31(11):1861-3. PubMed ID: 15553740
[TBL] [Abstract][Full Text] [Related]
13. [A case of recurrent early gastric cancer with peritonitis carcinomatosa successfully treated with TS-1].
Hatanaka F; Matsuo S; Aratake Y; Uchimura K; Yokota M; Sumii T; Iguchi H; Funakoshi A
Gan To Kagaku Ryoho; 2003 May; 30(5):703-6. PubMed ID: 12795106
[TBL] [Abstract][Full Text] [Related]
14. Toxic epidermal necrolysis associated with TS-1 in a patient with gastric cancer.
Tan CS; Lim R; Lim TC; Aw CW; Yeo SW; Lee SC
Jpn J Clin Oncol; 2011 May; 41(5):666-8. PubMed ID: 21415005
[TBL] [Abstract][Full Text] [Related]
15. Hand-foot syndrome variant in a dihydropyrimidine dehydrogenase-deficient patient treated with capecitabine.
Saif MW; Elfiky A; Diasio R
Clin Colorectal Cancer; 2006 Sep; 6(3):219-23. PubMed ID: 17026792
[TBL] [Abstract][Full Text] [Related]
16. Interstitial pneumonia possibly due to a novel anticancer drug, TS-1: first case report.
Kurakawa E; Kasuga I; Ishizuka S; Yoshida T; Kunisawa A; Minemura K; Utsumi K; Ohyashiki K
Jpn J Clin Oncol; 2001 Jun; 31(6):284-6. PubMed ID: 11463808
[TBL] [Abstract][Full Text] [Related]
17. [TS-1 treatment for progressive gastric cancer in a patient on chronic dialysis--assessment of dosage regimen by monitoring blood concentrations of therapeutic drugs (TDM)].
Tanaka T; Fujita S; Tanaka N; Ooka M; Okajima S; Tanaka N
Gan To Kagaku Ryoho; 2005 Jun; 32(6):841-5. PubMed ID: 15984528
[TBL] [Abstract][Full Text] [Related]
18. Case report: hand-foot syndrome induced by the oral fluoropyrimidine S-1.
Elasmar SA; Saad ED; Hoff PM
Jpn J Clin Oncol; 2001 Apr; 31(4):172-4. PubMed ID: 11386466
[TBL] [Abstract][Full Text] [Related]
19. [Examination of the feasibility of TS-1 for postoperative advance stomach cancer patients].
Hara A; Tokuhara T; Takahashi Y; Izumi N; Iwamoto S; Satake K
Gan To Kagaku Ryoho; 2004 Apr; 31(4):601-4. PubMed ID: 15114708
[TBL] [Abstract][Full Text] [Related]
20. Can inhibiting dihydropyrimidine dehydrogenase limit hand-foot syndrome caused by fluoropyrimidines?
Yen-Revollo JL; Goldberg RM; McLeod HL
Clin Cancer Res; 2008 Jan; 14(1):8-13. PubMed ID: 18172246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
